Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial.
Conditions
Tumor in Upper Gastrointestinal Canal or Patients With Colorectal Cancer.
Conditions: official terms
Colorectal Neoplasms
Conditions: Keywords
Colorectal Neoplasms, Depression, Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms, Digestive System Diseases, Gastrointestinal Diseases, Intestinal Diseases, Palliative chemotherapy, Palliative care, Palliative treatment, Quality of life, Quality of life for relatives, Survival
Study Type
Observational
Study Phase
N/A
Study Design
Time Perspective: Prospective
Intervention
Name: Contact with palliative care unit.
Type: Other
Overall Status
Recruiting
Summary
In this trial, patients with cancer in the upper gastrointestinal canal who are going to receive first line palliative chemotherapy and patients with colorectal cancer who are going to receive second line palliative chemotherapy will be included. Participating patients will be randomized between early contact with a palliative care unit, or contact with a palliative care unit when needed. The objectives with the trial is to investigate if an early establishment with a palliative care unit will have a positive impact on the patients quality of life, this also applies for the nearest relative, survival, and if a difference in numbers of chemotherapy cycles can be detected.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: N/A
Minimum Age: 18 Years
Gender: Both
Criteria: Inclusion Criteria:

- Patients with tumor in upper gastrointestinal canal, who is going to start treatment with first line palliative chemotherapy

- Patients with colorectal cancer, who is going to start treatment with second line palliative chemotherapy

- Signed written informed concent

Exclusion Criteria:

- Patients with neuroendocrine tumor

- Patients with already ongoing chemotherapy

- Patients with already established contact with palliative care unit
Location
Lund University Hospital
Lund, Sweden
Status: Recruiting
Contact: Mikael Segerlantz, MD, PhD - +46 46 17 70 91 - mikael.segerlantz@skane.se
Start Date
October 2014
Completion Date
October 2019
Sponsors
Lund University Hospital
Source
Lund University Hospital
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page